本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nurix Therapeutics

24.30
-1.2249-4.80%
成交量:47.75萬
成交額:1,171.96萬
市值:25.12億
市盈率:-7.12
高:25.50
開:25.47
低:24.27
收:25.52
52周最高:28.23
52周最低:8.20
股本:1.03億
流通股本:9,504.52萬
量比:0.67
換手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
淨資產收益率:-80.30%
總資產收益率:-40.06%
市淨率:6.24
市盈率(LYR):-7.96

資料載入中...

2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/08

重要事件披露

Form 8-K - Current report
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

重要事件披露

Form 8-K - Current report
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities